Form 10-Q Dipexium Pharmaceuticals For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Dipexium Pharmaceut (DPRX) Tops Q2 EPS by 2c
August 4, 2016 7:15 AM EDTDipexium Pharmaceut (NASDAQ: DPRX) reported Q2 EPS of ($0.52), $0.02 better than the analyst estimate of ($0.54).
For earnings history and earnings-related data on Dipexium Pharmaceut (DPRX) click here.
... More